| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 54.7× | −1.7× | |
| Price / Book | 8.5× | 2.0× | |
| Price / Sales | 8.8× | 3.9× | |
| Price / Free cash flow | 57.6× | −1.6× | |
| EV / EBITDA | 36.8× | −1.2× | |
| Earnings yield | 1.8% | −14.6% | |
| Free cash flow yield | 1.7% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,248.56 | −0.67% | $1.18T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $252.39 | −1.24% | $608.23B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.39 | −0.71% | $500.78B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $402.35 | +0.23% | $361.15B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.84 | −0.76% | $357.35B | 19.7× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.14 | −0.32% | $277.75B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $164.93 | −0.29% | $255.79B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $677.93 | −1.75% | $250.66B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $426.88 | −1.30% | $230.78B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $154.57 | −1.04% | $191.66B | 22.8× | 37.5% | +32.0% |
